Filing Details
- Accession Number:
- 0001641172-25-003675
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-04-10 19:02:33
- Reporting Period:
- 2025-04-08
- Filing Date:
- 2025-04-10
- Accepted Time:
- 2025-04-10 19:02:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1574094 | Renovorx Inc. | RNXT | Pharmaceutical Preparations (2834) | 271448452 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
2011160 | Ron Kocak | C/O Renovorx, Inc. 2570 W El Camino Real, Suite 320 Mountain View CA 94040 | Vp Controller And Pao | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-04-08 | 95 | $0.80 | 95 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2025-04-09 | 6,000 | $0.80 | 6,095 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2025-04-10 | 6,500 | $0.79 | 12,595 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- Reflects open market purchases of the Issuer's securities.